Alembic Pharmaceuticals Limited (APLLTD.BO)
INR 1045.0
(-1.04%)
INR 1045.0
(-1.04%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 5.13 Billion INR | -28.93% |
| 2022 | 7.22 Billion INR | 0.68% |
| 2021 | 7.17 Billion INR | 22.87% |
| 2020 | 5.83 Billion INR | -68.12% |
| 2019 | 18.3 Billion INR | 62.23% |
| 2018 | 11.28 Billion INR | 59.43% |
| 2017 | 7.07 Billion INR | 699.57% |
| 2016 | 885.2 Million INR | -35.67% |
| 2015 | 1.37 Billion INR | -45.13% |
| 2014 | 2.5 Billion INR | 129.23% |
| 2013 | 1.09 Billion INR | -41.43% |
| 2012 | 1.86 Billion INR | -47.04% |
| 2011 | 3.52 Billion INR | 28.37% |
| 2010 | 2.74 Billion INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 5.13 Billion INR | -28.93% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 5.13 Billion INR | 0.0% |
| 2023 Q2 | 8.68 Billion INR | 0.0% |
| 2022 Q4 | 7.22 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 FY | 7.22 Billion INR | 0.68% |
| 2022 Q2 | 7.7 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 FY | 7.17 Billion INR | 22.87% |
| 2021 Q4 | 7.17 Billion INR | 0.0% |
| 2021 Q2 | 9.41 Billion INR | 0.0% |
| 2020 Q4 | 5.83 Billion INR | 0.0% |
| 2020 FY | 5.83 Billion INR | -68.12% |
| 2020 Q2 | 6 Billion INR | 0.0% |
| 2019 Q2 | 13.18 Billion INR | 0.0% |
| 2019 Q4 | 18.3 Billion INR | 0.0% |
| 2019 FY | 18.3 Billion INR | 62.23% |
| 2018 FY | 11.28 Billion INR | 59.43% |
| 2018 Q4 | 11.28 Billion INR | 0.0% |
| 2018 Q2 | 10.89 Billion INR | 0.0% |
| 2017 Q4 | 7.07 Billion INR | 0.0% |
| 2017 Q2 | 3.67 Billion INR | 0.0% |
| 2017 FY | 7.07 Billion INR | 699.57% |
| 2016 Q4 | 885.2 Million INR | 0.0% |
| 2016 FY | 885.2 Million INR | -35.67% |
| 2016 Q2 | 1.44 Billion INR | 0.0% |
| 2015 FY | 1.37 Billion INR | -45.13% |
| 2015 Q2 | 1.31 Billion INR | 0.0% |
| 2015 Q4 | 1.37 Billion INR | 0.0% |
| 2014 Q4 | 2.5 Billion INR | 0.0% |
| 2014 FY | 2.5 Billion INR | 129.23% |
| 2014 Q2 | 2.03 Billion INR | 0.0% |
| 2013 Q4 | 1.09 Billion INR | 0.0% |
| 2013 FY | 1.09 Billion INR | -41.43% |
| 2013 Q2 | 1.56 Billion INR | 0.0% |
| 2012 Q2 | 1.62 Billion INR | 0.0% |
| 2012 FY | 1.86 Billion INR | -47.04% |
| 2012 Q4 | 1.86 Billion INR | 0.0% |
| 2011 FY | 3.52 Billion INR | 28.37% |
| 2010 FY | 2.74 Billion INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Ajanta Pharma Limited | 352.8 Million INR | -1354.535% |
| Amrutanjan Health Care Limited | 17.28 Million INR | -29591.604% |
| Sigachi Industries Limited | 1.43 Billion INR | -258.723% |
| Bal Pharma Limited | 1.39 Billion INR | -267.466% |
| Ind-Swift Laboratories Limited | 166.21 Million INR | -2987.308% |
| Medico Remedies Limited | 80.5 Million INR | -6274.342% |
| Lasa Supergenerics Limited | 220.76 Million INR | -2224.494% |
| Venus Remedies Limited | 413.3 Million INR | -1141.616% |
| Sun Pharma Advanced Research Company Limited | 611.5 Million INR | -739.182% |
| Alpa Laboratories Limited | 52.46 Million INR | -9680.997% |
| Nectar Lifesciences Limited | 6.35 Billion INR | 19.256% |
| Shilpa Medicare Limited | 9.37 Billion INR | 45.256% |
| Aarti Drugs Limited | 5.64 Billion INR | 9.058% |
| Lupin Limited | 29.21 Billion INR | 82.437% |
| Aurobindo Pharma Limited | 66.47 Billion INR | 92.281% |
| Zydus Lifesciences Limited | 8.04 Billion INR | 36.19% |
| Windlas Biotech Limited | 36.41 Million INR | -13993.93% |
| Suven Life Sciences Limited | 7.09 Million INR | -72206.608% |
| Eris Lifesciences Limited | 27.81 Billion INR | 81.549% |
| Valiant Laboratories Limited | 767.08 Million INR | -568.975% |
| J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | -35.879% |
| Solara Active Pharma Sciences Limited | 10.11 Billion INR | 49.267% |
| Ipca Laboratories Limited | 14.38 Billion INR | 64.323% |
| Bliss GVS Pharma Limited | 998.4 Million INR | -413.982% |
| Achyut Healthcare Limited | - INR | -Infinity% |
| Sun Pharmaceutical Industries Limited | 32.73 Billion INR | 84.325% |
| Bajaj HealthCare Limited | 3.32 Billion INR | -54.183% |
| RPG Life Sciences Limited | - INR | -Infinity% |
| Mankind Pharma Limited | 2.07 Billion INR | -147.697% |
| Laurus Labs Limited | 25.77 Billion INR | 80.09% |
| Piramal Pharma Limited | 47.1 Billion INR | 89.105% |
| Syncom Formulations (India) Limited | 724.86 Million INR | -607.938% |
| Torrent Pharmaceuticals Limited | 40.22 Billion INR | 87.241% |
| Glenmark Pharmaceuticals Limited | 12.3 Billion INR | 58.311% |
| Unichem Laboratories Limited | 2.47 Billion INR | -107.325% |
| Sequent Scientific Limited | 4.87 Billion INR | -5.222% |
| Novartis India Limited | 69.7 Million INR | -7262.41% |
| Wanbury Limited | 1.16 Billion INR | -340.539% |
| Suven Pharmaceuticals Limited | 649.96 Million INR | -689.521% |
| Wockhardt Limited | 23.56 Billion INR | 78.219% |
| Themis Medicare Limited | 957.92 Million INR | -435.701% |
| Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | -5639.403% |
| Jubilant Pharmova Limited | 36.64 Billion INR | 85.995% |
| Glenmark Life Sciences Limited | 171.48 Million INR | -2892.536% |
| Dr. Reddy's Laboratories Limited | 20.02 Billion INR | 74.368% |
| Divi's Laboratories Limited | 30 Million INR | -17005.333% |
| NATCO Pharma Limited | 3.71 Billion INR | -38.244% |
| Gufic Biosciences Limited | 3.32 Billion INR | -54.141% |
| IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | -1466.422% |
| Ind-Swift Limited | 10.13 Billion INR | 49.392% |
| Procter & Gamble Health Limited | 95.6 Million INR | -5267.782% |
| FDC Limited | 205.18 Million INR | -2400.963% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | -165.296% |
| Granules India Limited | 13.15 Billion INR | 60.978% |
| Medicamen Biotech Limited | 308.17 Million INR | -1565.174% |
| Alkem Laboratories Limited | 14.18 Billion INR | 63.821% |
| AstraZeneca Pharma India Limited | 45.98 Million INR | -11060.019% |
| Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -116819.572% |
| Brooks Laboratories Limited | 56.41 Million INR | -8995.517% |
| Megasoft Limited | 1.47 Billion INR | -248.977% |
| ZIM Laboratories Limited | 1.08 Billion INR | -371.549% |
| Strides Pharma Science Limited | 25.16 Billion INR | 79.611% |
| Neuland Laboratories Limited | 953.89 Million INR | -437.962% |
| Morepen Laboratories Limited | 289.99 Million INR | -1669.566% |
| Hikal Limited | 8.17 Billion INR | 37.234% |
| Indoco Remedies Limited | 6.71 Billion INR | 23.632% |
| Aarti Pharmalabs Limited | 2.85 Billion INR | -79.898% |
| Kilitch Drugs (India) Limited | 316.46 Million INR | -1521.538% |
| Mangalam Drugs & Organics Limited | 984.92 Million INR | -421.014% |
| Hester Biosciences Limited | 2.44 Billion INR | -109.986% |